Article

Fft.com on 2015-10-26 17:19

Valeant urges SEC to probe Citron claims

New York

Related news

MCitron Research urges media to take up baton on Valeant marketwatch.com
MMallinckrodt’s stock tumbles as short seller Citron claims next victim marketwatch.com
New York
Video: Valeant CEO: Sensational claims by Citron are completely untrue The Globe and Mail
FValeant dives on drug pricing probe ft.com
Massachusetts , United States , New York
Citron scales back attack on Valeant, won’t release further allegations The Globe and Mail
Canada
Citron Research’s Andrew Left: Meet the short seller behind those negative reports on Valeant Pharmaceuticals Inc business.financialpost.com
Florida , China
Valeant files overdue SEC report nwaonline.com
Wall Street , Canada
Video: Valeant asks SEC to investigate Citron allegations The Globe and Mail
FValeant shares tumble to three-year low ft.com
Pershing Square , Wall Street , Canada , New York
FValeant debacle claims Sequoia’s Goldfarb ft.com
New York
FAckman lifts Valeant stake as shares dive ft.com
China , New York
FValeant chief goes on leave with pneumonia ft.com
New Jersey , New York
FPharmacy groups cut ties to Valeant unit ft.com
New York
FValeant aims to sweeten $14.5bn Salix bid ft.com
Pershing Square , Canada , New York
FBlackstone pays $39m over SEC fees probe ft.com
New York
FSEC drops corruption probe into Cobalt ft.com
New York , Gulf of Mexico , Africa , Angola
Coinbase faces SEC probe over unregistered securities LA Times
New York , Washington
Valeant Pharmaceuticals subject of criminal probe: report Chicago Tribune
New York , Wall Street
A2 Milk's US suitor target of SEC insider trading probe Sydney Morning Herald
Russia , China , Australia , New York , Sur